InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry G. Steele Buys 3,000 Shares

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) CFO Barry G. Steele bought 3,000 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $5.76 per share, for a total transaction of $17,280.00. Following the transaction, the chief financial officer now owns 76,887 shares in the company, valued at $442,869.12. The trade was a 4.06% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

InfuSystem Trading Down 1.3%

INFU traded down $0.08 during midday trading on Tuesday, reaching $6.04. 3,649 shares of the company's stock traded hands, compared to its average volume of 92,583. The firm has a fifty day moving average of $5.28 and a two-hundred day moving average of $7.14. The stock has a market capitalization of $126.92 million, a price-to-earnings ratio of 100.52 and a beta of 1.73. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. InfuSystem Holdings, Inc. has a 52 week low of $4.61 and a 52 week high of $9.97.

Institutional Trading of InfuSystem

Several hedge funds and other institutional investors have recently made changes to their positions in INFU. Minerva Advisors LLC boosted its stake in InfuSystem by 7.5% during the 1st quarter. Minerva Advisors LLC now owns 910,677 shares of the company's stock valued at $4,899,000 after purchasing an additional 63,826 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in InfuSystem by 25.9% during the 4th quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock valued at $7,676,000 after purchasing an additional 186,668 shares during the last quarter. Meros Investment Management LP boosted its stake in InfuSystem by 2.6% during the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company's stock valued at $5,333,000 after purchasing an additional 16,178 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in InfuSystem by 5.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company's stock valued at $3,853,000 after purchasing an additional 21,697 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in InfuSystem by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock valued at $3,756,000 after purchasing an additional 7,968 shares during the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.

Wall Street Analysts Forecast Growth

INFU has been the subject of a number of recent analyst reports. StockNews.com downgraded InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 14th. B. Riley upgraded InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th. Finally, Sidoti upgraded InfuSystem to a "strong-buy" rating in a report on Tuesday, March 18th.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.